Mycobacterium kansasii
Mycobacterium kansasii is a species of the phylum Actinobacteria (Gram-positive bacteria with high guanine and cytosine content, one of the dominant phyla of all bacteria), belonging to the genus Mycobacterium.
Description[edit | edit source]
Mycobacterium kansasii is a non-tuberculous mycobacterium (NTM). It is photochromogenic, meaning it produces pigment when exposed to light. It is named after the state of Kansas where it was first isolated.
Pathogenesis[edit | edit source]
Mycobacterium kansasii is an opportunistic pathogen and can cause pulmonary disease resembling tuberculosis, lymphadenitis, and disseminated disease in immunocompromised patients. It is the second most common cause of NTM lung disease in the United States and is also frequently encountered in AIDS patients.
Treatment[edit | edit source]
The treatment of Mycobacterium kansasii involves a combination of antibiotics including rifampin, ethambutol, and isoniazid. The duration of treatment is typically 12 to 18 months.
See also[edit | edit source]
References[edit | edit source]
Mycobacterium kansasii Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD